Registry of Pavia Chronic Heart Failure Patients-observational Study

Registry of Pavia chronic heart failure patients-observational study

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Heart Failure Cardiovascular Diseases Heart Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Fondazione IRCCS Policlinico San Matteo di Pavia

Pavia, 27100, Italy

Location status: Recruiting

Location contact

Stefano Ghio

CONTACT

[email protected]

0382503158

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Give written informed consent to participate for the prospective evaluations
Suffer from CHF
Be aged 18 years and over

Exclusion criteria

Withdrawn of the consent

Treatment and study plan

Primary outcomes

accurate and comprehensive data collection for all types of diseases that manifest themselves with heart failure in order to verify the "trajectory" of the disease

Time frame: From enrollment to the end of treatment at visit 11 (9th years)

More specifically, mortality will be assessed one, five, and ten years after the initial diagnosis of heart failure.

Study contacts

Contact information is provided by the study sponsor or research team.

Stefano Ghio

CONTACT

[email protected]

0382503158

Sponsors and collaborators

Lead sponsor

Fondazione IRCCS Policlinico San Matteo di Pavia

Other

Registry information

Important dates

Study start: 2022
Primary completion: 2024
Study completion: 2031
First posted: Dec 18, 2025
Registry last updated: Dec 18, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting